Cybin Inc.
Market Cap
$413.02M
P/E Ratio
-2.20
EPS
$-3.77
Dividend Yield
0.00%
52-Week Range
$4.81 — $10.72
Volume
716.53K
Avg Volume
874.38K
Beta
—
P/E (TTM)
-2.20
Forward P/E
—
PEG Ratio
0.19
P/S (TTM)
0.00
P/B (TTM)
0.84
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-0.61%
ROA (TTM)
-0.45%
ROIC
—
Gross Margin
0.00%
Operating Margin
0.00%
Net Margin
—
Debt/Equity
0.00
Current Ratio
13.78
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-13.59%
EPS Growth (5Y)
-13423531.17%
Sales Growth (3Y)
+0.00%
Sales Growth (5Y)
-0.20%
EPS Est (This Year)
$-3.14
EPS Est (Next Year)
$-2.38
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$4.59
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
49.88M
Float
38.55M
Free Float %
77.29%
Sector
Healthcare
Industry
Biotechnology
Country
CA
Exchange
AMEX
IPO Date
2019-09-13
Employees
50
CEO
Eric So
Index Membership
—
Website
https://www.cybin.com
Cybin Inc. (CYBN) is a healthcare company in the biotechnology industry listed on the AMEX. With a market capitalization of $413.02M, a P/E ratio of -2.20, CYBN is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare CYBN against other stocks using dozens of fundamental and technical filters.
Cybin Inc. (CYBN) has a trailing twelve-month (TTM) P/E ratio of -2.20. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Cybin Inc. (CYBN) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Cybin Inc. (CYBN) has a market capitalization of $413.02 million, classifying it as a small-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.